Controversies in Thyroidology Virtual Program Accreditation Statement
Register for the ATA 2020 10-Webinar Summer Series as one convenient package or register for each webinar individually.REGISTER NOW
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Colorado School of Medicine and the American Thyroid Association®. The University of Colorado School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Colorado School of Medicine designates this other activity (combination of live and enduring activities) for 8.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 8.25 Medical Knowledge MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful completion of this CME activity, which includes participation in the evaluation component, enable the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification (CC) program (formerly known as MOC). It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of recognizing participation.
The University of Colorado School of Medicine will share participation information with ABIM and/or ABOHNS through PARS and the Accreditation Council for Continuing Medical Education (ACCME). This will include name, member ID, birth date, participation in the activity, the maximum allowable points, and the participant’s achieved points. Participant data is governed by those board’s Confidentiality Policy which may be found on their websites.
Links to evaluate and claim CME or MOC will be available after purchasing and viewing each program online. Please view the individual webinar listing for credit available per course.
Upon completion of the eight (8) webinars associated with this educational activity, learners should be able to:
- Become familiar with novel treatment strategies for thyroid nodules and cancer and how they compare to conventional surgical therapies
- Know the different ultrasonographic scoring systems and the benefits and limitations of each method in the evaluation and management of thyroid nodules
- Understand the role of surveillance in the evaluation and follow up of thyroid nodules and a subset of thyroid cancer
- Learn about molecular testing and its role at different points in the evaluation and treatment of thyroid nodules and thyroid cancer
- Become familiar with changing treatment paradigms for Grave’s disease and Grave’s ophthalmopathy
- Know the appropriate labs used to test thyroid disorders, and be familiar with limitations of various tests
|Completion of Learning Assessment by Participant||Credit Disseminated
(CME Certificates sent to Attendee Email provided and/or ABIM MOC Data Uploaded and/or ABOHNS MOC Data Uploaded)
|May 29, 2020 – August 31, 2020||September 15, 2020|
|September 1, 2020 – November 30, 2020||December 15, 2020|
|December 1, 2020 – February 28, 2021||March 15, 2021|
|March 1, 2021 – May 31, 2021||June 15, 2021|
|June 1, 2021 – August 31, 2021||September 15, 2021|